| CAPRNDA, M., P.. KUBATKA, K. GAZDIKOVA, I. GASPAROVA, V. VALENTOVA, N. STOLLAROVA, G. LA ROCCA, N. KOBYLIAK, J. DRAGASEK, I. MOZOS, R. PROSECKY, D. SINISCALCO, D. BUSSELBERG, L. RODRIGO and Peter KRUŽLIAK. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders. BIOMEDICINE & PHARMACOTHERAPY. PARIS: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2017, vol. 91, JUL 2017, p. 60-69. ISSN 0753-3322. Available from: https://dx.doi.org/10.1016/j.biopha.2017.04.034. |
Other formats:
BibTeX
LaTeX
RIS
@article{1398271,
author = {Caprnda, M. and Kubatka, P.. and Gazdikova, K. and Gasparova, I. and Valentova, V. and Stollarova, N. and La Rocca, G. and Kobyliak, N. and Dragasek, J. and Mozos, I. and Prosecky, R. and Siniscalco, D. and Busselberg, D. and Rodrigo, L. and Kružliak, Peter},
article_location = {PARIS},
article_number = {JUL 2017},
doi = {http://dx.doi.org/10.1016/j.biopha.2017.04.034},
keywords = {Stem cell therapy; Neurodegenerative disorders; Regenerative medicine},
language = {eng},
issn = {0753-3322},
journal = {BIOMEDICINE & PHARMACOTHERAPY},
title = {Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders},
volume = {91},
year = {2017}
}
TY - JOUR
ID - 1398271
AU - Caprnda, M. - Kubatka, P.. - Gazdikova, K. - Gasparova, I. - Valentova, V. - Stollarova, N. - La Rocca, G. - Kobyliak, N. - Dragasek, J. - Mozos, I. - Prosecky, R. - Siniscalco, D. - Busselberg, D. - Rodrigo, L. - Kružliak, Peter
PY - 2017
TI - Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders
JF - BIOMEDICINE & PHARMACOTHERAPY
VL - 91
IS - JUL 2017
SP - 60-69
EP - 60-69
PB - ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
SN - 07533322
KW - Stem cell therapy
KW - Neurodegenerative disorders
KW - Regenerative medicine
N2 - Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities. (C) 2017 Elsevier Masson SAS. All rights reserved.
ER -
CAPRNDA, M., P.. KUBATKA, K. GAZDIKOVA, I. GASPAROVA, V. VALENTOVA, N. STOLLAROVA, G. LA ROCCA, N. KOBYLIAK, J. DRAGASEK, I. MOZOS, R. PROSECKY, D. SINISCALCO, D. BUSSELBERG, L. RODRIGO and Peter KRUŽLIAK. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders. \textit{BIOMEDICINE \&{}amp; PHARMACOTHERAPY}. PARIS: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2017, vol.~91, JUL 2017, p.~60-69. ISSN~0753-3322. Available from: https://dx.doi.org/10.1016/j.biopha.2017.04.034.
|
